With the COVID-19 vaccination rate of adults receiving at least one dose now topping 60 percent in the U.S., and the Centers for Disease Control and Prevention (CDC) easing mask guidelines for those who have been vaccinated, recent grocery/CPG shopping data from shopper intelligence leader Catalina underscores the increasing enthusiasm for returning to a sense of normalcy sweeping the country after 15 months of varying degrees of restrictions. Continue reading
Clinical trials of the combination of Sputnik V and AstraZeneca vaccines will begin in February 2021
The studies will assess the immunogenicity and safety of combined vaccine usage
The joint research is important in developing an approach to combat future mutations Continue reading
AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more